ネブラスカ州における心血管疾患の臨床試験
ネブラスカ州内の拠点で、心血管疾患に関する10件の研究が参加者を募集しています。
ネブラスカ州内の都市
公式研究テキスト（英語）
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Methodist Physicians Clinic, Fremont
- Quality Clinical Research - Omaha, Omaha
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07064473Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- CHI Health Nebraska Heart, Grand Island
- Bryan Heart, Lincoln
- CHI Health Nebraska Heart, Lincoln
- 他1件
被験者募集中第4相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06909565Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Fremont
- Clinical Trial Site, Omaha
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07181109Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- University of Nebraska Medical Center, Omaha
被験者募集中
18歳〜100歳 · 全性別 · 2026/09/09更新 · NCT06310031Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- University of Nebraska Medical Center, Omaha
- Omaha VA Medical Center, Omaha
被験者募集中第4相健康なボランティア歓迎
75歳以上 · 全性別 · 2026/09/01更新 · NCT04262206A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Elkhorn
- Research Site, Fremont
- Research Site, Omaha
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/24更新 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Bryan Heart, Lincoln
- Physician Research Collaboration, LLC, Lincoln
被験者募集中第3相
50歳〜105歳 · 全性別 · 2026/08/21更新 · NCT07136012Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- University of Nebraska Medical Center, Omaha
被験者募集中
18歳以上 · 全性別 · 2026/06/10更新 · NCT06526195CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
被験者募集中第3相
18歳以上 · 全性別 · 2026/01/09更新 · NCT05931276ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。